Protecting Patient Access to Integrated GI Care in the Independent Setting

In an age when quality of care, cost-effectiveness and transparency are more important than ever, data demonstrates that high-quality, integrated care delivered in the independent medical practice setting is worthy of protection as an alternative to care that is often more costly when furnished in the hospital setting.

May 19, 2021

DHPA Supports USPSTF Recommendations for CRC Screening Beginning at Age 45 and More Research on Effectiveness of sDNA-FIT Screening on CRC Mortality Outcomes

DHPA voiced its support for the final recommendation by the U.S. Preventive Services Task Force (USPSTF) that Americans begin screening for colorectal cancer at the age of 45, an update of 2016 guidelines.
Continue Reading >>

January 28, 2021

DHPA Urges CMS to Rescind Ill-Conceived MFN Interim Final Rule

In a comment letter to the U.S. Centers for Medicare and Medicaid (CMS) regarding the Most Favored Nation (MFN) Interim Final Rule, DHPA wrote that the procedurally, statutorily and constitutionally flawed policy will severely restrict access to life-saving drug treatments and have adverse economic consequences for the Medicare program by shifting care from the more […]
Continue Reading >>

November 30, 2020

DHPA Opposes Most Favored Nation Rule Announced by CMS

The MFN Rule could dramatically restrict patient access to infusion medications administered in physician offices, especially for patients with Crohn’s disease and ulcerative colitis, which are both major categories of inflammatory bowel disease (IBD).
Continue Reading >>

November 2, 2020

DHPA Supports USPSTF Recommendations to Begin CRC Screening at 45, Calls for More Research on Disparities in Communities of Color

While supporting the draft recommendations overall, Dr. Glenn Littenberg, DHPA chair of health policy, expressed some concern about USPSTF’s recommendations with respect to screening colonoscopy versus stool-based CRC screening.
Continue Reading >>

July 14, 2020

Physicians, Patients Give Telehealth High Marks During COVID-19 Pandemic

Washington DC – A study in Clinical Gastroenterology and Hepatology suggests that telehealth services are an effective way to treat patients safely during periods of health care system disruption and shows that both patients and gastroenterology (GI) physicians overwhelmingly approve of telehealth services provided during the COVID-19 pandemic.
Continue Reading >>